Molecular targets and therapeutic strategies for triple-negative breast cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular targets and therapeutic strategies for triple-negative breast cancer
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-04
DOI
10.1007/s11033-023-08868-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide
- (2023) Udayan Bhattacharya et al. Cancers
- ACSL4: biomarker, mediator and target in quadruple negative breast cancer
- (2023) Marie E. Monaco Oncotarget
- PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers
- (2022) Linjie Luo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation
- (2022) Beate Vajen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer
- (2022) Utpalendu Paul et al. MOLECULAR BIOLOGY REPORTS
- Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer
- (2022) Yesol Kim et al. ONCOGENE
- miRNA-mediated Mitochondrial Dysfunction is Involved in the Anti-triple-negative Breast Cancer Cell Activity of Phytosesquiterpene Lactones
- (2022) Yu-Ting Cheng et al. ANTIOXIDANTS & REDOX SIGNALING
- Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness
- (2022) Farzaneh Darbeheshti et al. BMC CANCER
- Nanotechnological Approaches for the Treatment of Triple-Negative Breast Cancer: A Comprehensive Review
- (2022) Lahanya Guha et al. CURRENT DRUG METABOLISM
- Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
- (2022) Malvina Koni et al. Cancers
- Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
- (2022) Kajal Rajput et al. Cancers
- Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
- (2022) Xintong Li et al. CHINESE MEDICAL JOURNAL
- Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics
- (2021) Alessia Catalano et al. Antibiotics-Basel
- Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer
- (2021) Mam Y. Mboge et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment
- (2021) Mahsa Keihan Shokooh et al. Pharmaceutics
- Localized therapy using anti-PD-L1 anchored and NIR-responsive hollow gold nanoshell (HGNS) loaded with doxorubicin (DOX) for the treatment of locally advanced melanoma
- (2021) Asmita Banstola et al. Nanomedicine-Nanotechnology Biology and Medicine
- Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
- (2021) Miguel Martin et al. Scientific Reports
- Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes
- (2021) Maria Apostolidi et al. CANCER RESEARCH
- Identification of miRNAs and related hub genes associated with the triple negative breast cancer using integrated bioinformatics analysis and in vitro approach
- (2021) Mohd Shuaib et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
- (2021) Katsutoshi Sato et al. Nature Communications
- Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
- (2021) Ye Hu et al. Cancer Management and Research
- Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
- (2021) Nair Hariprasad Haritha et al. Frontiers in Oncology
- Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance
- (2021) Min Xia et al. CANCER LETTERS
- Novel immune targets for the treatment of triple-negative breast cancer
- (2021) Chiara Corti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
- (2021) Mirjana Prvanović et al. Life-Basel
- Anti-metastatic properties of a potent herbal combination in cell and mice models of triple negative breast cancer
- (2020) Laleh Arzi et al. LIFE SCIENCES
- Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
- (2020) Lamyae El Khalki et al. MOLECULES
- Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway
- (2020) Chenghuai Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immune Responses and Risk of Triple Negative Breast Cancer: Implications for Higher Rates among African American women
- (2020) Joshua W Ogony et al. Cancer Prevention Research
- Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism
- (2020) Rosanna Dattilo et al. CANCER RESEARCH
- Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer
- (2020) Christopher M. Bailey et al. Nanomedicine-Nanotechnology Biology and Medicine
- Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
- (2020) Antonio Marra et al. npj Breast Cancer
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
- (2020) Daniela Miricescu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
- (2020) Zimei Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
- (2019) Dnyaneshwar Kalyane et al. Materials Science & Engineering C-Materials for Biological Applications
- PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
- (2019) Xuan Jiang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
- (2019) Aarif Siddiqui et al. CELL DEATH AND DIFFERENTIATION
- GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation
- (2019) Michael Dougan et al. IMMUNITY
- A decade of clinical development of PARP inhibitors in perspective
- (2019) J Mateo et al. ANNALS OF ONCOLOGY
- Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway
- (2019) Xiaohong Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway
- (2019) Alexandre Vallée et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of novel inhibitors of signal transducer and activator of transcription 3 over signal transducer and activator of transcription 1 for the treatment of breast cancer by in-silico and in-vitro approach
- (2019) Stella Sravanthi V. et al. PROCESS BIOCHEMISTRY
- E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration
- (2019) Daniel P. Hollern et al. Scientific Reports
- Transformable Nanoparticle‐Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple‐Negative Breast Cancer Immunotherapy
- (2019) Chenfeng Xu et al. ADVANCED FUNCTIONAL MATERIALS
- TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer
- (2019) Brian D. Lehmann et al. CLINICAL CANCER RESEARCH
- Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer
- (2018) Babita Shashni et al. BIOMATERIALS
- The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer
- (2018) Xin An et al. BMC CANCER
- Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
- (2018) Shubin Yu et al. BMC Complementary and Alternative Medicine
- A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation
- (2018) Joyce O’Shaughnessy et al. BREAST CANCER RESEARCH AND TREATMENT
- Driver mutations in the mitogen-activated protein kinase pathway: the seeds of good and evil
- (2018) H. Kittler et al. BRITISH JOURNAL OF DERMATOLOGY
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality
- (2018) Marios Papadimitriou et al. CANCER TREATMENT REVIEWS
- Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy
- (2018) Soyoung Son et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of α-Mangostin on Viability, Growth and Cohesion of Multicellular Spheroids Derived from Human Breast Cancer Cell Lines
- (2018) Giuseppe Scolamiero et al. International Journal of Medical Sciences
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
- (2018) Melissa Davis et al. PLoS One
- Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
- (2018) Sarwar Hossen et al. Journal of Advanced Research
- Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo
- (2018) Wei-liang Chen et al. Acta Biomaterialia
- Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling
- (2018) Jixia Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts
- (2018) Alexey Koval et al. CANCER LETTERS
- Palbociclib after CDK and endocrine therapy (PACE): A randomized phase II study of fulvestrant, palbociclib, and avelumab for endocrine pre-treated ER+/HER2- metastatic breast cancer.
- (2018) Erica L. Mayer et al. JOURNAL OF CLINICAL ONCOLOGY
- Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
- (2018) Jie Li et al. Frontiers in Pharmacology
- Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
- (2018) Jun Tian et al. BRITISH JOURNAL OF CANCER
- Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways
- (2018) Marina Cruz-Lozano et al. EUROPEAN JOURNAL OF NUTRITION
- Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
- (2018) Houman Alimoradi et al. International Journal of Nanomedicine
- Osthole inhibits triple negative breast cancer cells by suppressing STAT3
- (2018) Xuanxuan Dai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Classification of triple-negative breast cancers based on Immunogenomic profiling
- (2018) Yin He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Characterization of the viscoelastic model of in vivo human posterior thigh skin using ramp-relaxation indentation test
- (2018) Seyed Jamaleddin Mostafavi Yazdi et al. KOREA-AUSTRALIA RHEOLOGY JOURNAL
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Self-renewal signaling pathways in breast cancer stem cells
- (2018) Lakshmi Vineela Nalla et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Application of microfluidic chip technology in pharmaceutical analysis: A review
- (2018) Ping Cui et al. Journal of Pharmaceutical Analysis
- The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells
- (2017) Yun Cai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dysregulation of microRNAs in triple-negative breast cancer
- (2017) Sylwia Paszek et al. Ginekologia Polska
- Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
- (2017) Amber L. Rowse et al. JOURNAL OF NEURO-ONCOLOGY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling
- (2017) Tao Zhou et al. ONCOLOGY REPORTS
- The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer
- (2017) Iram Fatima et al. PLoS One
- [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
- (2017) Ana Carolina B.M. Martin et al. Oncotarget
- Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- (2017) Natasha K. Brockwell et al. Cancer Immunology Research
- PD-1/PD-L1 Pathway in Breast Cancer
- (2017) Florian Schütz et al. Oncology Research and Treatment
- RNAi screens for Rho GTPase regulators of cell shape and YAP/TAZ localisation in triple negative breast cancer
- (2017) Patricia Pascual-Vargas et al. Scientific Data
- A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
- (2016) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition
- (2016) Shweta Shrivastava et al. BIOFACTORS
- Abstract P3-07-26: Biomarker comparison between androgen receptor – Positive-triple-negative breast cancer (AR+ TNBC) and quadruple-negative breast cancer (QNBC)
- (2016) J Xiu et al. CANCER RESEARCH
- Targeting the androgen receptor in triple-negative breast cancer
- (2016) Ayca Gucalp et al. CURRENT PROBLEMS IN CANCER
- WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells
- (2016) LIANG XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential microRNA expression is associated with androgen receptor expression in breast cancer
- (2016) Yaqin Shi et al. Molecular Medicine Reports
- Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
- (2016) Sara M. Tolaney et al. ONCOLOGIST
- Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression
- (2016) Dan Lin et al. ONCOLOGY REPORTS
- Inhibition of casein kinase 2 prevents growth of human osteosarcoma
- (2016) Kengo Takahashi et al. ONCOLOGY REPORTS
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment
- (2016) Wei Bin Fang et al. Oncotarget
- Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer
- (2016) Li Wang et al. Oncotarget
- Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
- (2016) Ken Takai et al. Oncotarget
- Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
- (2016) Giovanna Talarico et al. Scientific Reports
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Piperine inhibits the growth and motility of triple-negative breast cancer cells
- (2015) Anna L. Greenshields et al. CANCER LETTERS
- S-phase kinase-associated protein 2 expression interference inhibits breast cancer cell proliferation
- (2015) Y.J. Sun et al. GENETICS AND MOLECULAR RESEARCH
- Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
- (2015) Francisco E Vera-Badillo et al. JOURNAL OF CLINICAL PATHOLOGY
- Stimuli-responsive nanoparticles for targeting the tumor microenvironment
- (2015) Jinzhi Du et al. JOURNAL OF CONTROLLED RELEASE
- Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer
- (2015) Joseph Wahler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Targeting cancer stem cells in solid tumors by vitamin D
- (2015) Jae Young So et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Analytical and Simulation-Based Models for Drug Release and Gel-Degradation in a Tetra-PEG Hydrogel Drug-Delivery System
- (2015) Ralph Reid et al. MACROMOLECULES
- Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer
- (2015) Asha Srinivasan et al. MOLECULAR CARCINOGENESIS
- Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
- (2015) Ulises D. Orlando et al. Oncotarget
- Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment
- (2015) Guanlian Hu et al. Oncotarget
- Metastatic breast cancer cells in lymph nodes increase nodal collagen density
- (2015) Asif Rizwan et al. Scientific Reports
- Temporally Tunable, Enzymatically Responsive Delivery of Proangiogenic Peptides from Poly(ethylene glycol) Hydrogels
- (2015) Amy H. Van Hove et al. Advanced Healthcare Materials
- Silver(I)-Catalyzed Hydroazidation of Ethynyl Carbinols: Synthesis of 2-Azidoallyl Alcohols
- (2014) Zhenhua Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
- (2014) J.- C. Soria et al. ANNALS OF ONCOLOGY
- The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1and Cyclin D1 and induces cell cycle exit and neuronal differentiation
- (2014) Ulf Soppa et al. CELL CYCLE
- Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells
- (2014) Wenyan Lu et al. CELLULAR SIGNALLING
- Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24−/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
- (2014) MATEUSZ OPYRCHAL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
- (2014) Shulin Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer
- (2014) Sara Jansson et al. PLoS One
- Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy via Suppressing Wnt/β-Catenin Signaling Pathway
- (2014) Yujie Fu et al. PLoS One
- Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
- (2014) Dong Soon Choi et al. STEM CELLS
- Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status
- (2014) Songmi Noh et al. TUMOR BIOLOGY
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer
- (2013) Giuseppe Curigliano et al. BREAST
- Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
- (2013) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Therapeutic Applications of Herbal Medicines for Cancer Patients
- (2013) Shu-Yi Yin et al. Evidence-based Complementary and Alternative Medicine
- Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells
- (2013) Shulin Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- CREB3L1 Is a Metastasis Suppressor That Represses Expression of Genes Regulating Metastasis, Invasion, and Angiogenesis
- (2013) P. Mellor et al. MOLECULAR AND CELLULAR BIOLOGY
- Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
- (2013) Min Jiang et al. MOLECULES
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- Fucoidan Inhibited 4T1 Mouse Breast Cancer Cell Growth In Vivo and In Vitro Via Downregulation of Wnt/β-Catenin Signaling
- (2013) Meilan Xue et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
- (2013) Luciano Cascione et al. PLoS One
- Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
- (2013) Yu-Chi Wang et al. PLoS One
- Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast Cancer
- (2013) Xinyu Wu et al. PLoS One
- Hydrogel drug delivery system with predictable and tunable drug release and degradation rates
- (2013) G. W. Ashley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer
- (2013) Bo Li et al. PROSTATE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway
- (2013) Hongzhong Li et al. TOXICOLOGY LETTERS
- E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B
- (2013) David Engelmann et al. Journal of Molecular Cell Biology
- Global Screening of CK2 Kinase Substrates by an Integrated Phosphoproteomics Workflow
- (2013) Yangyang Bian et al. Scientific Reports
- Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
- (2013) Stefanie Regine Dannenmann et al. OncoImmunology
- Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC
- (2012) Ranjan Preet et al. CARCINOGENESIS
- Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells
- (2012) Wenyan Lu et al. CELLULAR SIGNALLING
- Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
- (2012) Lily Wu et al. CHEMISTRY & BIOLOGY
- Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway
- (2012) HONG PAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Expression of Dicer and Drosha in triple-negative breast cancer
- (2012) Nadia Passon et al. JOURNAL OF CLINICAL PATHOLOGY
- MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
- (2012) Dai Horiuchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells
- (2012) Shulin Zhang et al. PLoS One
- Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
- (2012) S. Volinia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Skp2 is a Promising Therapeutic Target in Breast Cancer
- (2012) Zhiwei Wang et al. Frontiers in Oncology
- A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells
- (2011) Asher Castiel et al. BMC CANCER
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
- (2011) R. S. Finn et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.
- (2011) Steven W. Cole et al. CLINICAL CANCER RESEARCH
- Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis
- (2011) Ida Johansson et al. GENES CHROMOSOMES & CANCER
- Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
- (2011) Yasuyo Ohi et al. HISTOPATHOLOGY
- Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity
- (2011) Ranjan Preet et al. INTERNATIONAL JOURNAL OF CANCER
- The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
- (2011) Taj D. King et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Donggen Liu et al. MEDICAL ONCOLOGY
- Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results
- (2011) Misako Nakagawa et al. Breast Cancer
- Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells
- (2010) Jingchun Gao et al. CANCER BIOLOGY & THERAPY
- Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
- (2010) Y. Li et al. CLINICAL CANCER RESEARCH
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate
- (2010) C. E. Strom et al. NUCLEIC ACIDS RESEARCH
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
- (2010) H. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy
- (2010) Muhammad Wasif Saif et al. Journal of Oncology
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Cancer-Cell Targeting and Photoacoustic Therapy Using Carbon Nanotubes as “Bomb” Agents
- (2009) Bin Kang et al. Small
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment
- (2008) Morgan O'Hayre et al. BIOCHEMICAL JOURNAL
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells
- (2008) H. Wang et al. JOURNAL OF CELL SCIENCE
- The emerging CK2 interactome: insights into the regulation and functions of CK2
- (2008) Laszlo Gyenis et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now